A PEDF-derived peptide inhibits retinal neovascularization and blocks mobilization of bone marrow-derived endothelial progenitor cells

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Ma, Jian Xing ^a   Longeras, Richard ^a   Farjo, Krysten ^b   Ihnat, Michael ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; PEDF 34 PEPTIDE; PEPTIDE; PIGMENT EPITHELIUM DERIVED FACTOR; UNCLASSIFIED DRUG; EYE PROTEIN; GREEN FLUORESCENT PROTEIN; NERVE GROWTH FACTOR; OXYGEN; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIAL PROGENITOR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; TRANSGENIC MOUSE; TREATMENT OUTCOME; ANIMAL; CATTLE; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; CHICK EMBRYO; CHORIOALLANTOIS; CYTOLOGY; DIABETIC RETINOPATHY; DISEASE MODEL; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STEM CELL; VASCULAR ENDOTHELIUM;

ANIMALS; BONE MARROW CELLS; CATTLE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; EYE PROTEINS; GREEN FLUORESCENT PROTEINS; MICE; MICE, TRANSGENIC; NERVE GROWTH FACTORS; OXYGEN; PEPTIDES; RECEPTOR, TIE-2; RETINAL NEOVASCULARIZATION; SERPINS; STEM CELLS;

EID: 80052721851     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/518426     Document Type: Article

References (27)

1. Battegay E. J., Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects Journal of Molecular Medicine 1995 73 7 333 346
2. Bouck N., PEDF: anti-angiogenic guardian of ocular function Trends in Molecular Medicine 2002 8 7 330 334 (Pubitemid 34733386)
3. Gao G., Li Y., Zhang D., Gee S., Crosson C., Ma J. X., Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization FEBS Letters 2001 489 2-3 270 276 (Pubitemid 32126422)
4. Miller J. W., Adamis A. P., Aiello L. P., Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy Diabetes Metabolism Reviews 1997 13 1 37 50 (Pubitemid 27213792)
5. Abu El-Asrar A. M., Struyf S., Verbeke H., Van Damme J., Geboes K., Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes Acta Ophthalmologica 2011 89 3 222 228
6. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., Inai Y., Silver M., Isner J. M., VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells EMBO Journal 1999 18 14 3964 3972 (Pubitemid 29335849)
7. Espinosa-Heidmann D. G., Caicedo A., Hernandez E. P., Csaky K. G., Cousins S. W., Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization Investigative Ophthalmology and Visual Science 2003 44 11 4914 4919 (Pubitemid 37315309)
8. Risau W., Flamme I., Vasculogenesis Annual Review of Cell and Developmental Biology 1995 11 73 91 (Pubitemid 26019602)
9. Flamme I., Frlich T., Risau W., Molecular mechanisms of vasculogenesis and embryonic angiogenesis Journal of Cellular Physiology 1997 173 2 206 210 (Pubitemid 27481131)
10. Risau W., Mechanisms of angiogenesis Nature 1997 386 6626 671 674 (Pubitemid 27193480)
11. Becerra S. P., Structure-function studies on PEDF: a noninhibitory serpin with neurotrophic activity Advances in Experimental Medicine and Biology 1997 425 223 237 (Pubitemid 28035786)
12. Dawson D. W., Volpert O. V., Gillis P., Crawford S. E., Xu H. J., Benedict W., Bouck N. P., Pigment epithelium-derived factor: a potent inhibitor of angiogenesis Science 1999 285 5425 245 248 (Pubitemid 29329995)
13. Ek E. T. H., Dass C. R., Choong P. F. M., PEDF: a potential molecular therapeutic target with multiple anti-cancer activities Trends in Molecular Medicine 2006 12 10 497 502 (Pubitemid 44468197)
14. Mori K., Duh E., Gehlbach P., Ando A., Takahashi K., Pearlman J., Mori K., Yang H. S., Zack D. J., Ettyreddy D., Brough D. E., Wei L. L., Campochiaro P. A., Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization Journal of Cellular Physiology 2001 188 2 253 263 (Pubitemid 32622916)
15. Stellmach V., Crawford S. E., Zhou W., Bouck N., Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2593 2597 (Pubitemid 32209527)
16. Amaral J., Becerra S. P., Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization Investigative ophthalmology amp; visual science 2010 51 3 1318 1326
17. Filleur S., Volz K., Nelius T., Mirochnik Y., Huang H., Zaichuk T. A., Aymerich M. S., Becerra S. P., Yap R., Veliceasa D., Shroff E. H., Volpert O. V., Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer Cancer Research 2005 65 12 5144 5152 (Pubitemid 40827323)
18. Smith L. E. H., Wesolowski E., McLellan A., Kostyk S. K., D'Amato R., Sullivan R., D'Amore P. A., Oxygen-induced retinopathy in the mouse Investigative Ophthalmology and Visual Science 1994 35 1 101 111 (Pubitemid 24046832)
19. Azzarello J., Ihnat M. A., Kropp B. P., Warnke L. A., Lin H. K., Assessment of angiogenic properties of biomaterials using the chicken embryo chorioallantoic membrane assay Biomedical Materials 2007 2 2, article 001 55 61 (Pubitemid 46795263)
20. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J. M., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circulation Research 1999 85 3 221 228 (Pubitemid 29377293)
21. Asahara T., Murohara T., Sullivan A., Silver M., Van Der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J. M., Isolation of putative progenitor endothelial cells for angiogenesis Science 1997 275 5302 964 967 (Pubitemid 27087709)
22. Kobari L., Giarratana M. C., Pflumio F., Izac B., Coulombel L., Douay L., CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells Journal of Hematotherapy and Stem Cell Research 2001 10 2 273 281 (Pubitemid 32423551)
23. Li T. S., Hamano K., Nishida M., Hayashi M., Ito H., Mikamo A., Matsuzaki M., CD117 stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation American Journal of PhysiologyHeart and Circulatory Physiology 2003 285 3 H931 H937 (Pubitemid 37048145)
24. Zhang S. X., Wang J. J., Gao G., Parke K., Ma J. X., Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy Journal of Molecular Endocrinology 2006 37 1 1 12 (Pubitemid 44288601)
25. Folkman J., Angiogenesis and apoptosis Seminars in Cancer Biology 2003 13 2 159 167 (Pubitemid 36315933)
26. Abe R., Shimizu T., Yamagishi S. I., Shibaki A., Amano S., Inagaki Y., Watanabe H., Sugawara H., Nakamura H., Takeuchi M., Imaizumi T., Shimizu H., Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo American Journal of Pathology 2004 164 4 1225 1232 (Pubitemid 38387789)
27. Doll J. A., Stellmach V. M., Bouck N. P., Bergh A. R. J., Lee C., Abramson L. P., Cornwell M. L., Pins M. R., Borensztajn J., Crawford S. E., Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas Nature Medicine 2003 9 6 774 780 (Pubitemid 36749229)